Join us for a special webinar:

De-Escalation of Axillary Surgery: Implications for Genomic Testing  and Adjuvant Chemotherapy  Decision-Making

Thursday, April 10, 2025 at 12:00pm ET

Faculty:

Jennifer M Racz, MD, MBA, FRCSC

Director, Medical Affairs, Oncology

Exact Sciences

Agenda

  • Discuss trends in de-escalation of surgical management of the breast and axilla
    in patients with early-stage breast cancer
  • Explore emerging data on de-escalation of axillary surgery
  • Consider the implications of omitting axillary surgery on genomic testing
    and adjuvant chemotherapy decision-making
Register Now

Exact Sciences Corporation Privacy Policy